HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Elevated Plasma Plasminogen Activator Inhibitor Type-1 is an Independent Predictor of Coronary Microvascular Dysfunction in Hypertension

Files in This Item:
tamaki_2007.pdf78.76 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/45965

Title: Elevated Plasma Plasminogen Activator Inhibitor Type-1 is an Independent Predictor of Coronary Microvascular Dysfunction in Hypertension
Authors: Naya, Masanao Browse this author
Tsukamoto, Takahiro Browse this author
Inubushi, Masayuki Browse this author
Morita, Koichi Browse this author
Katoh, Chietsugu Browse this author
Furumoto, Tomoo Browse this author
Fujii, Satoshi Browse this author
Tsutsui, Hiroyuki Browse this author
Tamaki, Nagara Browse this author →KAKEN DB
Keywords: Coronary circulation
Fibrinolysis
Hypertension
Plasminogen activator inhibitor type-1
Positron emission tomography
Issue Date: 2007
Publisher: 日本循環器学会
Journal Title: Circulation Journal
Volume: 71
Issue: 3
Start Page: 348
End Page: 353
Publisher DOI: 10.1253/circj.71.348
Abstract: Background :Elevated plasma plasminogen activator inhibitor-1 (PAI-1) is related to cardiovascular events, but its role in subclinical coronary microvascular dysfunction remains unknown. Thus, in the present study it was investigated whether elevated plasma PAI-1 activity is associated with coronary microvascular dysfunction in hypertensive patients. Methods and Results :Thirty patients with untreated essential hypertension and 10 age-matched healthy controls were studied prospectively. Myocardial blood flow (MBF) was measured by using 15O-water positron emission tomography. Clinical variables associated with atherosclerosis (low-density lipoprotein-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, homeostasis model assessment (HOMA-IR), and PAI-1 activity) were assessed to determine their involvement in coronary microvascular dysfunction. Adenosine triphosphate (ATP)-induced hyperemic MBF and coronary flow reserve (CFR) were significantly lower in hypertensive patients than in healthy controls (ATP-induced MBF: 2.77±0.82 vs 3.49±0.71 ml · g-1 · min-1; p<0.02 and CFR: 2.95 ±1.06 vs 4.25±0.69; p<0.001). By univariate analysis, CFR was positively correlated with HDL-cholesterol (r=0.46, p<0.02), and inversely with HOMA-IR (r=-0.39, p<0.05) and PAI-1 activity (r=-0.61, p<0.001). By multivariate analysis, elevated PAI-1 activity remained a significant independent determinant of diminished CFR. Conclusions :Elevated plasma PAI-1 activity was independently associated with coronary microvascular dysfunction, which suggests that plasma PAI-1 activity is an important clue linking hypofibrinolysis to the development of atherosclerosis. (Circ J 2007; 71: 348 - 353)
Type: article
URI: http://hdl.handle.net/2115/45965
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 玉木 長良

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

 - Hokkaido University